BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12931573)

  • 1. [Drug susceptibility of Trichosporon beigelii isolated from urine and clinical features of their hosts].
    Kouda M; Matsushima H; Homma S; Marumo K; Komine Y; Iizuka T
    Kansenshogaku Zasshi; 2003 Jul; 77(7):480-7. PubMed ID: 12931573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fungal urinary infection: report no. 1].
    Washida H; Tsugaya M; Hirao N; Sakagami H; Iwase Y
    Hinyokika Kiyo; 1986 Oct; 32(10):1543-6. PubMed ID: 3565191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichosporon beigelii infection: experience in a regional burn center.
    Cawley MJ; Braxton GR; Haith LR; Reilly KJ; Guilday RE; Patton ML
    Burns; 2000 Aug; 26(5):483-6. PubMed ID: 10812273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of Trichosporon beigelii to antifungal agents.
    Perparim K; Nagai H; Hashimoto A; Goto Y; Tashiro T; Nasu M
    J Chemother; 1996 Dec; 8(6):445-8. PubMed ID: 8981185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of flucytosine in patients with urinary fungal infections].
    Tokunaga S; Ohkawa M; Nakashima T; Yamaguchi K; Nishikawa T; Matsushita T; Mikawa I; Hirano S; Kawaguchi S; Miyagi T
    Jpn J Antibiot; 1992 Aug; 45(8):1060-4. PubMed ID: 1433895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal Trichosporon beigelii infection: report of a cluster of cases in a neonatal intensive care unit.
    Fisher DJ; Christy C; Spafford P; Maniscalco WM; Hardy DJ; Graman PS
    Pediatr Infect Dis J; 1993 Feb; 12(2):149-55. PubMed ID: 8426774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile].
    Silva V; Zepeda G; Alvareda D
    Rev Iberoam Micol; 2003 Mar; 20(1):21-3. PubMed ID: 12825977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal susceptibility testing of Trichosporon beigelii to imidazole compounds.
    McBride ME; Kalter DC; Wolf JE
    Can J Microbiol; 1988 Jul; 34(7):850-4. PubMed ID: 3196965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichosporon beigelii, an emerging pathogen resistant to amphotericin B.
    Walsh TJ; Melcher GP; Rinaldi MG; Lecciones J; McGough DA; Kelly P; Lee J; Callender D; Rubin M; Pizzo PA
    J Clin Microbiol; 1990 Jul; 28(7):1616-22. PubMed ID: 2380383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype, antifungal susceptibility, and biofilm formation of Trichosporon asahii isolated from the urine of hospitalized patients.
    Almeida AA; Crispim Bdo A; Grisolia AB; Svidzinski TI; Ortolani LG; Oliveira KM
    Rev Argent Microbiol; 2016; 48(1):62-6. PubMed ID: 26916812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogen Trichosporon isolated from Turkish patients.
    Kalkanci A; Sugita T; Arikan S; Yucesoy M; Ener B; Otag F; Kiraz N; Kustimur S; Sancak B; Evci C; Emektas G
    Med Mycol; 2010 Feb; 48(1):141-6. PubMed ID: 19462333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated Trichosporon beigelii infection in patients with malignant diseases: immunohistochemical study and review.
    Tashiro T; Nagai H; Kamberi P; Goto Y; Kikuchi H; Nasu M; Akizuki S
    Eur J Clin Microbiol Infect Dis; 1994 Mar; 13(3):218-24. PubMed ID: 8050434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units.
    Wolf DG; Falk R; Hacham M; Theelen B; Boekhout T; Scorzetti G; Shapiro M; Block C; Salkin IF; Polacheck I
    J Clin Microbiol; 2001 Dec; 39(12):4420-5. PubMed ID: 11724855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trichosporon beigelii funguria in renal transplant recipients.
    Lussier N; Laverdière M; Delorme J; Weiss K; Dandavino R
    Clin Infect Dis; 2000 Nov; 31(5):1299-301. PubMed ID: 11073770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocarditis due to Trichosporon beigelii: in vitro susceptibility of isolates and review.
    Keay S; Denning DW; Stevens DA
    Rev Infect Dis; 1991; 13(3):383-6. PubMed ID: 1866540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichosporonosis in patients with neoplastic disease.
    Walsh TJ; Newman KR; Moody M; Wharton RC; Wade JC
    Medicine (Baltimore); 1986 Jul; 65(4):268-79. PubMed ID: 3523114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan.
    Ruan SY; Chien JY; Hsueh PR
    Clin Infect Dis; 2009 Jul; 49(1):e11-7. PubMed ID: 19489711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of D0870, a novel triazole, against Candida lusitaniae and Trichosporon beigelii in experimental murine infections.
    Karyotakis NC; Dignani MC; Hachem R; Anaissie EJ
    Antimicrob Agents Chemother; 1995 Feb; 39(2):571-3. PubMed ID: 7726538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichosporon beigelii, a new neonatal pathogen.
    Yoss BS; Sautter RL; Brenker HJ
    Am J Perinatol; 1997 Feb; 14(2):113-7. PubMed ID: 9259910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Disseminated Trichosporon beigelii infection: report of nine cases and review].
    Tashiro T; Nagai H; Yamasaki T; Goto Y; Akizuki S; Nasu M
    Kansenshogaku Zasshi; 1993 Aug; 67(8):704-11. PubMed ID: 8409577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.